Johns Hopkins Kimmel Cancer Center Completed Phase I Trial of Intravenous Mistletoe

BelieveBigPress Release

Non-profit Believe Big funded research shows mistletoe treatment safe and improves quality of life for cancer patients. Hunt Valley, Maryland — February 23, 2023 — The first mistletoe therapy clinical trial in the United States utilizing intravenous Mistletoe has been completed by oncologists at the Johns Hopkins Kimmel Cancer Center. Spearheaded by Believe Big, a non-profit cancer assistance organization founded … Read More

First U.S. Study of Mistletoe Extract to Treat Cancer – Johns Hopkins Kimmel Cancer Center – Press Release

BelieveBigPress Release

First U.S. Study of Mistletoe Extract to Treat Cancer Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but questions remain due to a lack of clinical trials and data to support its use. Researchers at the Johns Hopkins Kimmel Cancer Center completed the first Phase I intravenous trial in the U.S. aimed at … Read More

Mistletoe: The holiday plant is making headlines as an alternative cancer treatment

BelieveBigPress Release

Mistletoe’s big season may have just ended, but its role as an anticancer agent could be just getting started. An oncologist at Johns Hopkins successfully treated a patient who had advanced colon cancer with an extract of the seasonal botanical, sparking interest in the plant’s anticancer properties. The Smithsonian Institution describes mistletoe as a semiparasitic plant in the order of flowering … Read More

Cancer survivor drives Hopkins mistletoe therapy trials

BelieveBigPress Release

Cancer survivor drives Hopkins mistletoe therapy trials By BY BARBARA PASH SEP 11, 2013 AT 8:02 AM Iveliesse Page is the founder of Believe Big, an anti-cancer non profit in Reisterstown. Believe Big is raising funds for a clinical trial at Johns Hopkins Medicine’s Kimmel Cancer Center. (Photo by Karen Jackson) Ivelisse Page is on a mission. In 2011, Page launched Believe Big, a … Read More